138 related articles for article (PubMed ID: 8531335)
21. Hyper-IgM syndrome: a case report.
Wang IJ; Wang SJ; Yan DC; Lin SJ; Chiang BL
J Microbiol Immunol Infect; 2003 Sep; 36(3):215-7. PubMed ID: 14582569
[TBL] [Abstract][Full Text] [Related]
22. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome.
Allen RC; Armitage RJ; Conley ME; Rosenblatt H; Jenkins NA; Copeland NG; Bedell MA; Edelhoff S; Disteche CM; Simoneaux DK
Science; 1993 Feb; 259(5097):990-3. PubMed ID: 7679801
[TBL] [Abstract][Full Text] [Related]
23. Central nervous system toxoplasmosis with an increased proportion of circulating gamma delta T cells in a patient with hyper-IgM syndrome.
Leiva LE; Junprasert J; Hollenbaugh D; Sorensen RU
J Clin Immunol; 1998 Jul; 18(4):283-90. PubMed ID: 9710745
[TBL] [Abstract][Full Text] [Related]
24. Abnormal CD40-mediated activation pathway in B lymphocytes from patients with hyper-IgM syndrome and normal CD40 ligand expression.
Durandy A; Hivroz C; Mazerolles F; Schiff C; Bernard F; Jouanguy E; Revy P; DiSanto JP; Gauchat JF; Bonnefoy JY; Casanova JL; Fischer A
J Immunol; 1997 Mar; 158(6):2576-84. PubMed ID: 9058789
[TBL] [Abstract][Full Text] [Related]
25. Bone marrow transplantation as treatment for X-linked immunodeficiency with hyper-IgM.
Bordigoni P; Auburtin B; Carret AS; Schuhmacher A; Humbert JC; Le Deist F; Sommelet D
Bone Marrow Transplant; 1998 Dec; 22(11):1111-4. PubMed ID: 9877275
[TBL] [Abstract][Full Text] [Related]
26. Hyper-immunoglobulin M syndrome caused by a mutation in the promotor for CD40L.
Van Hoeyveld E; Zhang PX; De Boeck K; Fuleihan R; Bossuyt X
Immunology; 2007 Apr; 120(4):497-501. PubMed ID: 17244160
[TBL] [Abstract][Full Text] [Related]
27. Hyper-IgM immunodeficiency with disseminated cryptococcosis.
Iseki M; Anzo M; Yamashita N; Matsuo N
Acta Paediatr; 1994 Jul; 83(7):780-2. PubMed ID: 7949815
[TBL] [Abstract][Full Text] [Related]
28. Clinical spectrum of X-linked hyper-IgM syndrome.
Levy J; Espanol-Boren T; Thomas C; Fischer A; Tovo P; Bordigoni P; Resnick I; Fasth A; Baer M; Gomez L; Sanders EA; Tabone MD; Plantaz D; Etzioni A; Monafo V; Abinun M; Hammarstrom L; Abrahamsen T; Jones A; Finn A; Klemola T; DeVries E; Sanal O; Peitsch MC; Notarangelo LD
J Pediatr; 1997 Jul; 131(1 Pt 1):47-54. PubMed ID: 9255191
[TBL] [Abstract][Full Text] [Related]
29. Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM.
Ferrari S; Giliani S; Insalaco A; Al-Ghonaium A; Soresina AR; Loubser M; Avanzini MA; Marconi M; Badolato R; Ugazio AG; Levy Y; Catalan N; Durandy A; Tbakhi A; Notarangelo LD; Plebani A
Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12614-9. PubMed ID: 11675497
[TBL] [Abstract][Full Text] [Related]
30. A boy with X-linked hyper-IgM syndrome and natural killer cell deficiency.
Ostenstad B; Giliani S; Mellbye OJ; Nilsen BR; Abrahamsen T
Clin Exp Immunol; 1997 Feb; 107(2):230-4. PubMed ID: 9030857
[TBL] [Abstract][Full Text] [Related]
31. Intrinsic defect in B cells of patients with hyper-immunoglobulin M syndrome.
Porat YB; Levy D; Levy J; Zan-Bar I
Clin Diagn Lab Immunol; 1995 Jul; 2(4):412-6. PubMed ID: 7583916
[TBL] [Abstract][Full Text] [Related]
32. Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction.
Klaus SJ; Pinchuk LM; Ochs HD; Law CL; Fanslow WC; Armitage RJ; Clark EA
J Immunol; 1994 Jun; 152(12):5643-52. PubMed ID: 7515910
[TBL] [Abstract][Full Text] [Related]
33. CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans.
Weller S; Faili A; Garcia C; Braun MC; Le Deist F F; de Saint Basile G G; Hermine O; Fischer A; Reynaud CA; Weill JC
Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1166-70. PubMed ID: 11158612
[TBL] [Abstract][Full Text] [Related]
34. CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimer.
Subauste CS; Wessendarp M; Sorensen RU; Leiva LE
J Immunol; 1999 Jun; 162(11):6690-700. PubMed ID: 10352287
[TBL] [Abstract][Full Text] [Related]
35. Mutations of CD40 ligand in two patients with hyper-IgM syndrome.
García-Pérez MA; Paz-Artal E; Corell A; Moreno A; López-Goyanes A; García-Martín F; Vázquez R; Pacho A; Romo E; Allende LM
Immunobiology; 2003; 207(4):285-94. PubMed ID: 12952351
[TBL] [Abstract][Full Text] [Related]
36. Long-term study of a female hyper-IgM immunodeficiency.
Kaneko H; Fukao T; Inoue R; Kasahara K; Matsui E; Kondo N
Exp Clin Immunogenet; 2000; 17(4):173-8. PubMed ID: 11096255
[TBL] [Abstract][Full Text] [Related]
37. Recurrent acalculous cholecystitis and sclerosing cholangitis in a patient with X-linked hyper-immunoglobulin M syndrome.
Lin SC; Shyur SD; Ma YC; Huang LH; Lee HC; Lee WI
J Formos Med Assoc; 2005 Jun; 104(6):421-6. PubMed ID: 16037832
[TBL] [Abstract][Full Text] [Related]
38. Trans-splicing repair of CD40 ligand deficiency results in naturally regulated correction of a mouse model of hyper-IgM X-linked immunodeficiency.
Tahara M; Pergolizzi RG; Kobayashi H; Krause A; Luettich K; Lesser ML; Crystal RG
Nat Med; 2004 Aug; 10(8):835-41. PubMed ID: 15273748
[TBL] [Abstract][Full Text] [Related]
39. Non-X-linked hyper-IgM syndrome with systemic lupus erythematosus.
Arai J; Yasukawa M; Takada K; Tange Y; Saiki O; Horiuchi T; Tamai T; Fujita S
Clin Exp Rheumatol; 1998; 16(1):84-6. PubMed ID: 9543571
[TBL] [Abstract][Full Text] [Related]
40. [X-linked hyper-IGM syndrome associated to sclerosing cholangitis and gallbladder neoplasm: clinical case].
Rodríguez C; Carrión F; Marinovic MA; Chávez E; Preisler J; Pooley F; Futatani T; Ochs HD
Rev Med Chil; 2003 Mar; 131(3):303-8. PubMed ID: 12790080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
